Top Markets
Coin of the day
Hemagen Diagnostics, Inc. Hemagen Diagnostics, Inc.

Hemagen Diagnostics, Inc.

HMGN
株式のランク #42231
Hemagen Diagnostics, Inc., a global biotechnology firm, specializes in... Hemagen Diagnostics, Inc., a global biotechnology firm, specializes in delivering clinical diagnostic solutions for both human and animal health. The company designs, manufactures, and distributes the VIRGO product line, a series of human clinical immunoassays used for identifying autoimmune and infectious diseases, as well as acute phase proteins. Its comprehensive human diagnostic portfolio also encompasses Universal IFA components, various supplies, controls, calibrators, accessories, H-rotors, reagents, electrodes, equipment, and specialized assays covering conditions such as Chagas, acute phase proteins, and cytokines. For the veterinary market, Hemagen Diagnostics provides diagnostic equipment, reagents, consumables, accessories, and electrodes crucial for chemistry, hematology, and electrolyte analysis. The company reaches a diverse customer base, including laboratories, hospitals, and blood banks, through both direct sales and an extensive distribution network. Established in 1985, Hemagen Diagnostics maintains its headquarters in Columbia, Maryland.
株価
$0.0002
最終同期: 2026-08-11
時価総額
$3.10K
変化(1日)
0.00%
変化(1年)
100.00%
US
取引 Hemagen Diagnostics, Inc. (HMGN)

カテゴリー

Hemagen Diagnostics, Inc.(HMGN)の配当利回りの履歴
Hemagen Diagnostics, Inc.(銘柄コード: HMGN)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Hemagen Diagnostics, Inc.(HMGN)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)